Blum, Hubert E.

Publishing since 1982 (Dinosaur)

Has published 373 publications in 29 years

Number of publications published per year by Blum, Hubert E.. (Source : PubMed)

Distribution of publications types for Blum, Hubert E.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, Fleming V, Flint J, Willberg CB, Bengsch B, Seigel B, Ramamurthy N, Zitzmann N, Barnes EJ, Thevanayagam J, Bhagwanani A, Leslie A, Oo YH, Kollnberger S, Bowness P, Drognitz O, Adams DH, Blum HE, Thimme R, Klenerman P. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.  Proc. Natl. Acad. Sci. U.S.A.  2010;107;7  
•  Fischer R, Breidert M, Paul S, Kreisel W, Schmitt-Gräff A, Waller C, Blum HE. [A patient with chronic diarrhoe, head pigmentation and alopecia. Cronkhite-Canada syndrome]  Dtsch. Med. Wochenschr.  2010;135;8  
•  Neumann-Haefelin C, Timm J, Schmidt J, Kersting N, Fitzmaurice K, Oniangue-Ndza C, Kemper MN, Humphreys I, McKiernan S, Kelleher D, Lohmann V, Bowness P, Huzly D, Rosen HR, Kim AY, Lauer GM, Allen TM, Barnes E, Roggendorf M, Blum HE, Thimme R. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.  Hepatology  2010;51;1  
•  Langenberg MH, van Herpen CM, De Bono J, Schellens JH, Unger C, Hoekman K, Blum HE, Fiedler W, Drevs J, Le Maulf F, Fielding A, Robertson J, Voest EE. Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.  J. Clin. Oncol.  2009;27;36  
•  Himmelsbach K, Sauter D, Baumert TF, Ludwig L, Blum HE, Hildt E. New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.  Gut  2009;58;12  
•  Bartosch B, Thimme R, Blum HE, Zoulim F. Hepatitis C virus-induced hepatocarcinogenesis.  J. Hepatol.  2009;51;4  
•  Harder J, Waiz O, Otto F, Geissler M, Olschewski M, Weinhold B, Blum HE, Schmitt-Graeff A, Opitz OG. EGFR and HER2 expression in advanced biliary tract cancer.  World J. Gastroenterol.  2009;15;36  
•  Billerbeck E, Nakamoto N, Seigel B, Blum HE, Chang KM, Thimme R. Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection.  J. Gen. Virol.  2009;90;Pt 7  
•  Spangenberg HC, Thimme R, Blum HE. Targeted therapy for hepatocellular carcinoma.  Nat Rev Gastroenterol Hepatol  2009;6;7  
•  Bellecave P, Gouttenoire J, Gajer M, Brass V, Koutsoudakis G, Blum HE, Bartenschlager R, Nassal M, Moradpour D. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference.  Hepatology  2009;50;1  

[ See timeline ] [ See all publications ]